Abstract:Cancer is a borderless global health challenge that continues to threaten human health. Studies have found that oxidative stress (OS) is often associated with the etiology of many diseases, especially the aging process and cancer. Involved in the OS reaction as a key transcription factor, Nrf2 is a pivotal regulator of cellular redox state and detoxification. Nrf2 can prevent oxidative damage by regulating gene expression with antioxidant response elements (ARE) to promote the antioxidant response process. OS is generated with an imbalance in the redox state and promotes the accumulation of mutations and genome instability, thus associated with the establishment and development of different cancers. Nrf2 activation regulates a plethora of processes inducing cellular proliferation, differentiation and death, and is strongly associated with OS-mediated cancer. What's more, Nrf2 activation is also involved in anti-inflammatory effects and metabolic disorders, neurodegenerative diseases, and multidrug resistance. Nrf2 is highly expressed in multiple human body parts of digestive system, respiratory system, reproductive system and nervous system. In oncology research, Nrf2 has emerged as a promising therapeutic target. Therefore, certain natural compounds and drugs can exert anti-cancer effects through the Nrf2 signaling pathway, and blocking the Nrf2 signaling pathway can reduce some types of tumor recurrence rates and increase sensitivity to chemotherapy. However, Nrf2's dual role and controversial impact in cancer are inevitable consideration factors when treating Nrf2 as a therapeutic target. In this review, we summarized the current state of biological characteristics of Nrf2 and its dual role and development mechanism in different tumor cells, discussed Keap1/Nrf2/ARE signaling pathway and its downstream genes, elaborated the expression of related signaling pathways such as AMPK/mTOR and NF-κB. Besides, the main mechanism of Nrf2 as a cancer therapeutic target and the therapeutic strategies using Nrf2 inhibitors or activators, as well as the possible positive and negative effects of Nrf2 activation were also reviewed. It can be concluded that Nrf2 is related to OS and serves as an important factor in cancer formation and development, thus provides a basis for targeted therapy in human cancers.

Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Role of hypoxia in the hallmarks of human cancer.

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

Hypoxia Signaling in Cancer: Implications for Therapeutic Interventions

Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?

Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype

Hypoxia: Intriguing Feature in Cancer Cell Biology

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes

Hypoxic tumor microenvironment: Implications for cancer therapy

HIF-1α pathway: role, regulation and intervention for cancer therapy

Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Role of hypoxia in the tumor microenvironment and targeted therapy

Tumor hypoxia: From basic knowledge to therapeutic implications

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Cancer Therapy by Targeting Hypoxia-Inducible Factor-1.

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation